Social Media 4277 Posted January 7 Share Posted January 7 Alzheimer’s drug Leqembi was approved Friday after clinical trial results found it slowed decline in people with mild impairment — but it's not without risks Quote Link to post Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.